“TMPRSS11D and TMPRSS13 Activate the SARS-CoV-2 Spike Protein”
by Mai Kishimoto, Kentaro Uemura, Takao Sanaki, Akihiko Sato, William W. Hall, Hiroaki Kariwa, Yasuko Orba, Hirofumi Sawa and Michihito Sasaki
Viruses 2021, 13(3), 384; https://doi.org/10.3390/v13030384
Available online: https://www.mdpi.com/1999-4915/13/3/384

“Quinine Inhibits Infection of Human Cell Lines with SARS-CoV-2”
by Maximilian Große, Natalia Ruetalo, Mirjam Layer, Dan Hu, Ramona Businger, Sascha Rheber, Christian Setz, Pia Rauch, Janina Auth, Maria Fröba et al.
Viruses 2021, 13(4), 647; https://doi.org/10.3390/v13040647
Available online: https://www.mdpi.com/1999-4915/13/4/647

“mRNA-lncRNA Co-Expression Network Analysis Reveals the Role of lncRNAs in Immune Dysfunction during Severe SARS-CoV-2 Infection”
by Sumit Mukherjee, Bodhisattwa Banerjee, David Karasik and Milana Frenkel-Morgenstern
Viruses 2021, 13(3), 402; https://doi.org/10.3390/v13030402
Available online: https://www.mdpi.com/1999-4915/13/3/402

“The Pro-Inflammatory Chemokines CXCL9, CXCL10 and CXCL11 Are Upregulated Following SARS-CoV-2 Infection in an AKT-Dependent Manner”
by Victoria Callahan, Seth Hawks, Matthew A. Crawford, Caitlin W. Lehman, Holly A. Morrison, Hannah M. Ivester, Ivan Akhrymuk, Niloufar Boghdeh, Rafaela Flor, Carla V. Finkielstein et al.
Viruses 2021, 13(6), 1062; https://doi.org/10.3390/v13061062
Available online: https://www.mdpi.com/1999-4915/13/6/1062

“Modeling within-Host SARS-CoV-2 Infection Dynamics and Potential Treatments”
by Mehrshad Sadria and Anita T. Layton
Viruses 2021, 13(6), 1141; https://doi.org/10.3390/v13061141
Available online: https://www.mdpi.com/1999-4915/13/6/1141

“Resveratrol and Pterostilbene Inhibit SARS-CoV-2 Replication in Air–Liquid Interface Cultured Human Primary Bronchial Epithelial Cells”
by Bram M. ter Ellen, Nilima Dinesh Kumar, Ellen M. Bouma, Berit Troost, Denise P. I. van de Pol, Heidi H. van der Ende-Metselaar, Leonie Apperloo, Djoke van Gosliga, Maarten van den Berge, Martijn C. Nawijn et al.
Viruses 2021, 13(7), 1335; https://doi.org/10.3390/v13071335
Available online: https://www.mdpi.com/1999-4915/13/7/1335

“SARS-CoV-2 N Protein Targets TRIM25-Mediated RIG-I Activation to Suppress Innate Immunity”
by Gianni Gori Savellini, Gabriele Anichini, Claudia Gandolfo and Maria Grazia Cusi
Viruses 2021, 13(8), 1439; https://doi.org/10.3390/v13081439
Available online: https://www.mdpi.com/1999-4915/13/8/1439

“Robust Neutralizing Antibody Levels Detected after Either SARS-CoV-2 Vaccination or One Year after Infection”
by Stefan Glöckner, Franziska Hornung, Michael Baier, Sebastian Weis, Mathias W. Pletz, Stefanie Deinhardt-Emmer, Bettina Löffler and the CoNAN Study Group
Viruses 2021, 13(10), 2003; https://doi.org/10.3390/v13102003
Available online: https://www.mdpi.com/1999-4915/13/10/2003

“Macrophages and Monocytes: “Trojan Horses” in COVID-19”
by Elena Percivalle, Josè Camilla Sammartino, Irene Cassaniti, Eloisa Arbustini, Mario Urtis, Alexandra Smirnova, Monica Concardi, Cristina Belgiovine, Alessandro Ferrari, Daniele Lilleri et al.
Viruses 2021, 13(11), 2178; https://doi.org/10.3390/v13112178
Available online: https://www.mdpi.com/1999-4915/13/11/2178

“SARS-CoV-2 Infects Human ACE2-Negative Endothelial Cells through an αvβ3 Integrin-Mediated Endocytosis Even in the Presence of Vaccine-Elicited Neutralizing Antibodies”
by Antonella Bugatti, Federica Filippini, Marta Bardelli, Alberto Zani, Paola Chiodelli, Serena Messali, Arnaldo Caruso and Francesca Caccuri
Viruses 2022, 14(4), 705; https://doi.org/10.3390/v14040705
Available online: https://www.mdpi.com/1999-4915/14/4/705